Is hydroxychloroquine beneficial for COVID-19 patients?
et al., Cell Death & Disease volume 11, doi:10.1038/s41419-020-2721-8 (Review) (Peer Reviewed) (not included in the study count)
Review of the anti-inflammatory, antiviral, and protective vascular effects of CQ and HCQ, noting that HCQ may be preferable for COVID-19 due to fewer side effects.
Li et al., 7/8/2020, peer-reviewed, 8 authors.
Please send us corrections, updates, or comments.